# CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

> **NCT00176462** · PHASE2 · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 60 (actual)

## Conditions studied

- Acute Lymphocytic Leukemia

## Interventions

- **DRUG:** aminopterin
- **DRUG:** L-asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunomycin
- **DRUG:** dexamethasone
- **DRUG:** 6-mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** 6-thioguanine
- **DRUG:** vincristine
- **DRUG:** Triple Intrathecal Therapy (MTX, Cytarabine, Hydrocortisone)
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT00176462
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176462, "CINJALL: Treatment for Children With Acute Lymphocytic Leukemia". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00176462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*